THC

CBD (cannabidiol), an important cannabinoid component of the cannabis plant, is a pharmacologically broad-spectrum drug that has attracted increasing attention in recent years as a treatment for a range of neuropsychiatric disorders. The potential of CBD as a treatment for depression-related disorders was determined by evaluating evidence from preclinical, human, clinical, and epidemiological studies. The […]

Neurodegenerative diseases leading to Parkinson’s disease (PD) and Alzheimer’s disease (AD) have become a major global health burden. Current treatments are mainly aimed at controlling symptoms, and there are no effective treatments in clinical practice to prevent neurodegeneration or induce neuronal repair. Therefore, the need for new research on these two diseases is urgent. The […]

A research project funded by the National Institute on Drug Abuse will be published in the journal PLoS ONE to explore whether cannabis-derived CBD can help people with cannabis use disorder reduce or stop using THC. The study uses a double-blind randomized trial to target people who heavily use cannabis concentrates and want to quit […]

Recent Court Ruling: A Breakthrough for the Cannabis Industry The recent court ruling represents a significant victory for the hemp and cannabis industries, paving the way for product development and research. Specifically, the legalization of Delta-8 THC marks a pivotal point with potential for industry-wide change, offering new opportunities for market expansion. Medical Potential: Therapeutic […]